Jacob Edwards
Pediatrics · Decatur, GANPI 1730323254
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,074 and has fallen 86.0% since, to $151 in 2025. Among pediatrics clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 129 payments — averaging $20.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- QOL Medical, LLC$428
- Jazz Pharmaceuticals Inc.$301
- Novo Nordisk$188
- Tris Pharma Inc$180
- Corium, LLC$177
- Eisai Inc.$152
- plus $1K from 34 others
What the payments were for
- Food & beverage$2,64199%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| QOL Medical, LLC | 16 | $428 |
| Jazz Pharmaceuticals Inc. | 11 | $301 |
| Novo Nordisk | 5 | $188 |
| Tris Pharma Inc | 5 | $180 |
| Corium, LLC | 15 | $177 |
| Eisai Inc. | 8 | $152 |
| Rhythm Pharmaceuticals, Inc. | 5 | $119 |
| UCB, Inc. | 5 | $108 |
| Xeris Pharmaceuticals, Inc. | 6 | $103 |
| Ascendis Pharma Endocrinology Inc | 4 | $73 |
| Sanofi | 3 | $66 |
| Greenwich Biosciences, Inc. | 4 | $59 |
| Ironshore Pharmaceuticals Inc. | 3 | $58 |
| Ultragenyx Pharmaceutical Inc. | 2 | $47 |
| Tolmar, Inc. | 3 | $45 |
| AbbVie | 3 | $40 |
| Sunovion Pharmaceuticals Inc. | 3 | $39 |
| Merck | 2 | $39 |
| Aquestive Therapeutics, Inc. | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| Livanova USA, Inc. | 1 | $30 |
| Neos Therapeutics, LP | 2 | $30 |
| Arbor Pharmaceuticals, Inc. | 2 | $29 |
| Neurelis, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| GSK | 1 | $22 |
| Amgen | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Sobi, Inc | 1 | $18 |
| Pharming Healthcare, Inc. | 1 | $18 |
| Eton Pharmaceuticals, Inc. | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Zogenix Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| SK Life Science, Inc. | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Biomarin Pharmaceutical Inc. | 1 | $14 |
| Pfizer | 1 | $12 |
| Aprecia Pharmaceuticals, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$118
- Quillivant$118
- Quillichew ER$118
How this compares
$2,673 in reported general payments places this provider in the 95th percentile of 2,111 pediatrics providers in Georgia.
Other pediatrics in Decatur
- Amir AshrafiAtlanta$563K
- Sandra ArmsteadLithonia$424K
- Satheesh ChonatAtlanta$147K
- Karen ZimowskiAtlanta$139K
- F CantrellMarietta$129K
- Iyabode Akinsanya-BeysolowAtlanta$103K
- Lauren MiddlebrooksAtlanta$71K
- Rebecca EmoryAtlanta$40K
- Mark GriffithsAtlanta$34K
- Kelly TickleAtlanta$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.